Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

Ana Custodio,Alberto Carmona-Bayonas,Paula Jiménez-Fonseca,Marta Sánchez,A. Viudez,Raquel Hernández,Juana María Cano,Isabel Echavarria,Carles Pericay,Montserrat Mangas,Laura Visa,E. Buxo,Teresa Garcia,A Rodriguez Palomo,Fj Alvarez Manceñido,A. Lacalle,Ismael Macias,Aitor Azkarate,Avinash Ramchandani,A. Fernández Montes,C. López,Federico Longo,R. Sánchez-Bayona,Maria Luisa Limón,Asunción Díaz-Serrano,Alicia Hurtado,Rosario Madero,C Gómez,Javier Gallego

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

2017

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

Keywords:

Medicine
Pathology
Prospective cohort study
Trastuzumab
Chemotherapy
Adenocarcinoma
Confidence interval
combination chemotherapy
Derivation
Nomogram
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations